Stockscreener 앱 받기
13.42
0.00%
0.00
시간 외 거래:
13.40
-0.02
-0.15%
전일 마감가:
$13.42
열려 있는:
$13.42
하루 거래량:
2.73M
Relative Volume:
0.33
시가총액:
$3.52B
수익:
$6.16B
순이익/손실:
$246.00M
주가수익비율:
14.30
EPS:
0.9387
순현금흐름:
$708.00M
1주 성능:
+0.30%
1개월 성능:
+0.15%
6개월 성능:
+91.99%
1년 성능:
+36.24%
1일 변동 폭
$13.42
$13.47
1주일 범위
$13.40
$13.49
52주 변동 폭
$5.69
$13.49
오가논 & Co Stock (OGN) Company Profile
명칭
Organon Co
전화
551-430-6000
주소
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, NVS, MRK
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.42 | 3.53B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,112.00 | 1.01T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
234.20 | 567.28B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
221.23 | 391.50B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
150.88 | 289.19B | 54.66B | 13.58B | 16.05B | 7.0171 |
MRK
Merck Co Inc
|
115.44 | 283.78B | 65.51B | 8.93B | 14.12B | 3.5532 |
오가논 & Co Stock (OGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-10-27 | 다운그레이드 | Piper Sandler | Overweight → Underweight |
| 2025-05-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-09-06 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-11-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-09-21 | 개시 | Barclays | Overweight |
| 2023-03-16 | 개시 | Raymond James | Outperform |
| 2022-10-14 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-09-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 개시 | Piper Sandler | Neutral |
| 2021-09-01 | 개시 | BofA Securities | Buy |
| 2021-07-22 | 개시 | Citigroup | Buy |
| 2021-06-15 | 개시 | JP Morgan | Neutral |
| 2021-06-11 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 개시 | Evercore ISI | Outperform |
모두보기
오가논 & Co 주식(OGN)의 최신 뉴스
Is TOFIDENCE’s Expanded CRS and COVID Label Altering The Investment Case For Organon (OGN)? - Yahoo Finance
Organon (OGN) director Shalini Sharp receives 17,857 phantom stock units as cash-settled award - Stock Titan
Organon (OGN) director Ramona Sequeira receives 17,857 phantom stock units as cash-settled award - Stock Titan
Organon (OGN) director receives 17.8K phantom stock units as compensation - Stock Titan
Organon (OGN) director granted cash-settled phantom stock tied to shares - Stock Titan
Organon (OGN) director awarded 17,857 phantom stock units as cash-settled compensation - Stock Titan
Organon (OGN) director receives phantom stock award, lifting holdings above 81,000 units - Stock Titan
Organon (OGN) director awarded 17,857 phantom stock units under savings plan - Stock Titan
Organon (OGN) director Alan Ezekowitz awarded 17,857 phantom stock units - Stock Titan
Organon (OGN) director awarded phantom stock units tied to shares - Stock Titan
Organon wins FDA nod to expand TOFIDENCE use in severe CRS & COVID-19 - MSN
Sun Pharma to acquire US-based Organon in nearly $11.75 billion deal - DD News
Press Release: Organon Reports Results for the First Quarter Ended March 31, 2026 - Moomoo
OGNOrganon & Co Stock Price and Quote - Finviz
Sun Pharma to buy Organon for $11.75B in record overseas deal - MSN
Organon & Co. Announces Results of 2026 Annual Meeting and Approves Incentive Stock Plan in Form 8-K Filing - Minichart
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19 - Zacks Investment Research
Sector Gamma AS Has $2.15 Million Stock Position in Organon & Co. $OGN - MarketBeat
Private Management Group Inc. Acquires 1,204,979 Shares of Organon & Co. $OGN - MarketBeat
Organon & Co stock hits 52-week high at 13.48 USD - Investing.com Nigeria
Organon (NYSE: OGN) holders back amended 2021 incentive plan adding 8M shares - Stock Titan
Organon & Co. (NYSE:OGN) Sets New 1-Year HighStill a Buy? - MarketBeat
Brandes Investment Partners LP Has $4.35 Million Stock Holdings in Organon & Co. $OGN - MarketBeat
Organon & Co. (OGN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Organon wins US approval to widen use of arthritis biosimilar drug - ETPharma.com
OGN News | ORGANON & CO (NYSE:OGN) - ChartMill
Sun Pharma seals $11.8 bn Organon deal, eyes global top 25 spot - MSN
SBI Set to Join Global Lenders Backing Sun Pharma's USD 12 Billion Organon Acquisition - Medical Dialogues
FDA expands Organon’s tocilizumab biosimilar indications - Investing.com UK
Organon & Co. (NYSE:OGN) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Organon Expands Tofidence Label With FDA Approval for Additional Indications - marketscreener.com
FDA expands Organon’s tocilizumab biosimilar indications By Investing.com - Investing.com Australia
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE - Business Wire
Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
SBI Set to Join Global Lenders in Funding Sun Pharma’s $12 Bn Organon Acquisition - outlookbusiness.com
SBI May Commit $1 Billion to Support Sun Pharma’s $12 Billion Organon Acquisition - India Infoline
SBI in $1 billion funding for Sun Pharma’s US deal - The Economic Times
What Sparked Organon's Recent Stock Surge - Kavout
(OGN) Risk Channels and Responsive Allocation - Stock Traders Daily
Sun Pharma to acquire Organon in US$11bn deal - FemTech World
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
OGN Technical Analysis | Trend, Signals & Chart Patterns | ORGANON & CO (NYSE:OGN) - ChartMill
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Organon & Co. (OGN) - marketscreener.com
OGN CLASS ACTION NEWS: Organon & Co. Shareholders that Suffered Losses are Alerted of the Upcoming July 22 Securities Fraud Class Action Deadline - TMX Newsfile
OGN Stock Price, Quote & Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Sun Pharma, Organon filed HSR May 21, waiting period expires June 22 - MLex
OGN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Organon (OGN) to be Acquired by Sun Pharma for $14.00 Cash per Share - Stock Titan
Sun Pharma bought the dip in its $11.7B Organon deal. Just not the right kind of dip - The Ken
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Yahoo Finance
오가논 & Co (OGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.46%
0.23%
자본화:
|
볼륨(24시간):